Norepinephrine Not Yet Recruiting Phase 3 Trials for Shock, Cardiogenic Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03340779Norepinephrine vs Norepinephrine and Dobutamine in Cardiogenic Shock